Advertisement
Advertisement

PROK

PROK logo

ProKidney Corp. Class A Ordinary Shares

1.88
USD
Sponsored
+0.15
+8.38%
Feb 06, 15:56 UTC -5
Closed
exchange

After-Market

1.88

0.00
+0.27%

PROK Earnings Reports

Positive Surprise Ratio

PROK beat 11 of 13 last estimates.

85%

Next Report

Date of Next Report
Mar 13, 2026
Estimate for Q4 25 (Revenue/ EPS)
$85.00K
/
-$0.11
Implied change from Q3 25 (Revenue/ EPS)
-60.83%
/
-8.33%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-35.29%

ProKidney Corp. Class A Ordinary Shares earnings per share and revenue

On Nov 10, 2025, PROK reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.13 USD, resulting in a 10.85% surprise. Revenue reached 217.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a +3.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 85.00 thousand USD, implying an decrease of -8.33% EPS, and decrease of -60.83% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, ProKidney Corp. Class A Ordinary Shares reported EPS of -$0.12, beating estimates by 10.85%, and revenue of $217.00K, 0% as expectations.
The stock price moved up 3.7%, changed from $2.70 before the earnings release to $2.80 the day after.
The next earning report is scheduled for Mar 13, 2026.
Based on 9 analysts, ProKidney Corp. Class A Ordinary Shares is expected to report EPS of -$0.11 and revenue of $85.00K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement